7,376.86

+23.13

+0.31%

51,285.73

-237.37

-0.46%

24,579.42

+264.42

+1.09%

2,754.11

+24.22

+0.89%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,074.90

-38.60

-0.94%

75,838.42

+146.20

+0.19%

Crude Oil Dec 26

90.83

+0.31

+0.34%

US Private Equity

10,772.76

+11.83

+0.11%

NSE - Delayed Quote INR

Fortis Healthcare Limited (FORTIS.NS)

773.65 -46.15 (-5.63%)

At close: 3:29:30 PM GMT+5:30

Loading Chart for FORTIS.NS

Chart Range Bar

Interval:

In partnership with ChartIQ

Fortis Healthcare to Install India's First Upright Proton Therapy System, Advancing Precision Cancer Care

Fortis Healthcare to Install India's First Upright Proton Therapy System, Advancing Precision Cancer Care

Fortis Healthcare Ltd (BOM:532843) (Q1 2027) Earnings Call Highlights: Revenue Surges 17. ...

Fortis Healthcare Ltd (BOM:532843) (Q1 2027) Earnings Call Highlights: Revenue Surges 17. ...

Fortis Healthcare Ltd (BOM:532843) Q4 2026 Earnings Call Highlights: Strong Revenue Growth and ...

Fortis Healthcare Ltd (BOM:532843) Q4 2026 Earnings Call Highlights: Strong Revenue Growth and ...

Daiichi Sankyo (TSE:4568) Faces Fresh Court Uncertainty After Appeal In Fortis Case

Daiichi Sankyo (TSE:4568) Faces Fresh Court Uncertainty After Appeal In Fortis Case

Fortis Healthcare Ltd (BOM:532843) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...

Fortis Healthcare Ltd (BOM:532843) Q2 2026 Earnings Call Highlights: Strong Revenue Growth Amid ...

India Semaglutide Patent Expiry Could Drive 50% Price Drop in Weight-Loss Drugs

India Semaglutide Patent Expiry Could Drive 50% Price Drop in Weight-Loss Drugs

Mobilize your Website

View Site in Mobile | Classic

Share by: